Entero Healthcare Solutions Limited announced that its board has approved the execution of a Share Purchase Agreement (SPA) to acquire a 60% stake in Ace Cardiopathy Solutions Private Limited, subject to satisfactory completion of due diligence and execution of the definitive agreements.
The cost of acquisition shall range between ₹59.30 Crore to ₹77.10 Crore for acquiring 60% stake in the target company, subject to adjustments for net debt, normalized working capital, and achievement of certain conditions. The acquisition is expected to be completed by January 31, 2026.
Ace Cardiopathy is engaged in the business of wholesale distribution of medical devices and other healthcare and allied products. The paid-up equity share capital of Ace Cardiopathy is ₹29.81 Lakhs.
Details of Acquisition
| Particulars | Details |
|---|---|
| Name of the target entity | M/s. Ace Cardiopathy Solutions Private Limited |
| Industry | Wholesale distribution of medical devices and other healthcare and allied products |
| Cost of acquisition | ₹59.30 Crore to ₹77.10 Crore |
| Percentage of shareholding acquired | 60% |
| Completion Date | January 31, 2026 |
| Consideration | Cash |
Ace Cardiopathy Financials
The revenue details of Ace Cardiopathy are as follows:
| Name of the Company | F.Y - 2024-2025 (Unaudited) | F.Y - 2023-2024 (Audited) | F.Y - 2022-2023 (Audited) |
|---|---|---|---|
| Ace Cardiopathy | 1548 | 1762 | 1530 |
In a separate announcement, Entero Healthcare also informed about the sale of its entire stake (100%) in Suprabhat Pharmaceutical Private Limited, a wholly-owned subsidiary of the Company.
The details of Income and Networth of Suprabhat Pharmaceutical Private Limited are as follows:
| Particulars | Amount (INR in millions) | Percentage (%) |
|---|---|---|
| Income | 198.76 | 0.39 |
| Networth | 2.38 | 0.01 |
Note: As per the audited financial statements as on March 31, 2025. Percentage reflects Suprabhat's contribution to Entero's Consolidated Income/net worth
The buyers do not belong to the promoter, promoter group of the Company. However, they were erstwhile promoters of Suprabhat.
The transaction would be considered as Related Party Transaction and shall be on an Arm's Length basis.
The Board Meeting commenced at 11:30 AM (IST) and concluded at 01:20 PM (IST).
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
